��������

Together, we have a chance to design coordinated systems of support for patients and their families – next-generation care that will build a nation of healthier communities.

he Medicaid and CHIP Payment and Access Commission today released its March 2019 report to Congress, which recommends Congress phase in the Affordable Care Act’s Medicaid Disproportionate Share Hospital reductions over a longer period and restructure the DSH allotment methodology based on the number of low-income individuals in a state.

A record 33,417 medical school seniors and graduates were matched to U.S. residency positions today through the National Resident Matching Program, 1,518 more than last year.

The Centers for Medicare & Medicaid Services today

The Arizona Hospital and Healthcare Association yesterday named Ann-Marie Alameddin as its president and CEO effective April 2.

As our country works to expand health coverage and improve access to care, “Medicare for All” is getting a lot of attention. There are many different flavors so it’s worth diving a little deeper into what “Medicare for All” really means. A new report released on Tuesday shows exactly what one proposed “Medicare for All” bill would do – and how it will impact hospitals, health systems and patients’ access to care.

Reps. Terri Sewell, D-Ala., and John Katko, R-N.Y., today introduced the Resident Physician Shortage Reduction Act of 2019 (H.R. 1763) that would add up to 15,000 Medicare-funded residency positions over five years, similar to an AHA-supported bill (S. 348) introduced last month in the Senate.   

The Senate Appropriations Committee’s Subcommittee on Labor, Health and Human Services, Education and Related Agencies today held a

Legislative proposals for a Medicare public option could negatively affect patient access to care and significantly reduce payments to hospitals, AHA Executive Vice President Tom Nickels said during a panel discussion today at America’s Health Insurance Plans’ National Health Policy Conference in Washington, D.C. The panel focused on the hospital perspective on health reform. 

The Centers for Medicare & Medicaid Services today released new state tools and guidance that provide standard monitoring metrics and recommended research methods for Section 1115 demonstrations that test innovative approaches to Medicaid eligibility and coverage policies.

The Centers for Medicare & Medicaid Services today updated its Medicare and Medicaid drug spending dashboards with 2017 data.

The House Energy and Commerce Health Subcommittee today held a hearing to discuss seven bills aimed at increasing competition in the prescription drug market to lower prices.

Prior authorization still poses significant challenges to physicians and patients, according to a new survey b

The American Board of Medical Specialties Board of Directors yesterday announced its plan to implement recommendations to improve the continuing certification process.

Creating a government-run, Medicare-like option on the individual health insurance exchanges could negatively affect patient access to care and reduce hospital payments by nearly $800 billion over 10 years.

The House Energy and Commerce Health Subcommittee today held a hearing on the president’s fiscal year 2020 budget request for the Department of Health and Human Services.

A federal court has ordered a Texas-based company to stop producing compounded drug products intended to be sterile until the company complies with the Federal Food, Drug, and Cosmetic Act and other requirements.

The Centers for Medicare & Medicaid Services last week announced planned changes to the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies Competitive Bidding Program for 2021.

Adjusting for social risk factors such as poverty, disability and housing instability in the Hospital Readmissions Reduction Program could level the playing field for hospitals that serve the most vulnerable patients.

The Department of Veterans Affairs and Sioux Falls, S.D.-based Sanford Health will provide free pharmacogenetic testing to veterans through a partnership to improve care and lower costs related to adverse reactions to medications.